ADCK2 and breast neuroendocrine neoplasm: After observing that ADCK2 pathogenetic or unknown variant rates were substantially different between breast NET and IDC, we determined also the mRNA and protein levels of ADCK2 in the breast NET samples (Supplementary Fig. 12).